000 01746 a2200505 4500
005 20250514220556.0
264 0 _c20050505
008 200505s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/cncr.20964
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCantore, Maurizio
245 0 0 _aPhase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
_h[electronic resource]
260 _bCancer
_cApr 2005
300 _a1402-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aBiliary Tract Neoplasms
_xdrug therapy
650 0 4 _aCholangiocarcinoma
_xdrug therapy
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aEpirubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHepatic Artery
650 0 4 _aHumans
650 0 4 _aInfusions, Intra-Arterial
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeutropenia
_xchemically induced
650 0 4 _aSurvival Rate
650 0 4 _aVenous Thrombosis
_xetiology
700 1 _aMambrini, Andrea
700 1 _aFiorentini, Giammaria
700 1 _aRabbi, Carla
700 1 _aZamagni, Donatella
700 1 _aCaudana, Roberto
700 1 _aPennucci, Cristina
700 1 _aSanguinetti, Franco
700 1 _aLombardi, Mirko
700 1 _aNicoli, Nicola
773 0 _tCancer
_gvol. 103
_gno. 7
_gp. 1402-7
856 4 0 _uhttps://doi.org/10.1002/cncr.20964
_zAvailable from publisher's website
999 _c15401399
_d15401399